Status:
UNKNOWN
Monocytes and NK Cells Activity in Covid-19 Patients
Lead Sponsor:
Università degli Studi dell'Insubria
Conditions:
COVID-19
Severe Acute Respiratory Syndrome Coronavirus 2
Eligibility:
All Genders
18+ years
Brief Summary
SARS-CoV-2 belong to beta-coronavirus family and its transmission route and symptoms follow those of all community-acquired coronaviruses. The main difference of the novel Coronavirus is the higher mo...
Detailed Description
According to the medical hypothesis on which the protocol is based on, young people could benefit from a functional adaptation of innate immune cells induced through epigenetic reprogramming and, espe...
Eligibility Criteria
Inclusion
- Age: ≥ 18
- SARS-CoV-2 documented infection
Exclusion
- Refusal to the sign the agreement (informed consent);
- Inability to sign the agreement;
- HIV, HCV, HBV (positive to HBsAg) infection.
Key Trial Info
Start Date :
April 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04375176
Start Date
April 27 2020
End Date
October 31 2020
Last Update
May 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ATS Insubria
Varese, Italy, 21100